The trademark RIBOXIN was filed by GLOBAL MEDICUS, SIA, a corporation established under the laws of the Republic of Latvia (the "Applicant"). The application was published for oppositions on January 30, 2023, and received one opposition filed on April 17, 2023 by FAES FARMA, S.A. on Likelihood of confusion. the opponent was represented by Alvarez López, Sonia and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued April 17, 2023
The application was filed in Latvian, and Latvian was also language of all opposition proceedings (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on October 2, 2023.